PCRLJN 2019

2019 P Cr (PLP)

Messrs TIANSHI INTERNATIONAL PAKISTAN CO. (PVT.) LTD. and another — Petitioners Versus FEDERATION OF PAKISTAN and others — Respondents

Jurisdiction / Court
Sindh
Decided Date
2017-August-22
Honorable Judges
N/A
Case Reference Summary (AEO Optimized)
Citation 2019 P Cr (PLP)
Forum / Court Sindh
Bench Members N/A
Parties Messrs TIANSHI INTERNATIONAL PAKISTAN CO. (PVT.) LTD. and another — Petitioners Versus FEDERATION OF PAKISTAN and others — Respondents
Primary Law (a) Drugs Act (XXXI of 1976), (d) Interpretation of statutes, (b) Interpretation of statutes
💡 Quick Legal QA & Summary / سوال و جواب خلاصہ
Q1: What are the key laws and sections cited in 2019 P Cr (PLP)?

This judgment primarily cites: (a) Drugs Act (XXXI of 1976), (d) Interpretation of statutes, (b) Interpretation of statutes, (c) Administration of justice as referenced in Pakistani case law index.

Q2: Which judicial bench decided the case 2019 P Cr (PLP)?

The case was heard and decided by the Sindh bench comprising: N/A.

Q3: What is the official citation format for this judgment on Pakistan Law Portal?

Cite this legal precedent as: 2019 P Cr (PLP) (Messrs TIANSHI INTERNATIONAL PAKISTAN CO. (PVT.) LTD. and another — Petitioners Versus FEDERATION OF PAKISTAN and others — Respondents). Read the full summary and cross-referenced laws free on Pakistan Law Portal.

Laws Cited

(a) Drugs Act (XXXI of 1976) (d) Interpretation of statutes (b) Interpretation of statutes (c) Administration of justice

Representation

  • ----Ss. 23, 27, 30 & 33---Drugs Regulatory Authority of Pakistan Act (XXI of 2012), Ss. 3(2b), 7, 29, 30, 32 & Sched. IV---Import, export, manufacting and sale of spurious, counterfeit, misbranded, substandard, unwarranted, unregistered, smuggled drugs---"Drug"---Definition---Scope---Quashing of FIR---Scope---Petitioner, a private limited company was engaged in business in Pakistan for the last thirteen years and imported products including perfumes, cosmetics, healthcare devices, food supplements---Such products were based on five thousand years of traditional Chinese healthcare culture and traditional methods based on plants and herbs, which being food supplements were neither drugs nor medicines, not covered by definition of "drugs" under the Drugs Act, 1976---Provincial Inspector of Drugs made a report to the FIA that petitioner company was engaged in selling, supplying, distribution of suspected spurious, counterfeit, sub-standard, unwarranted, unregistered drug products under the garb of food supplements, healthcare products which was a cognizable offence under the Act and requested FIA for joint action for inspection/raid and investigation, which was without jurisdiction---Joint Team of FIA and Provincial Inspectorate of Drugs, while acting promptly, conducted a raid at the premises of the petitioner-company and warehouse, seized various products, arrested employee and distributor of company and registered the FIR---Validity---Record showed that department had attempted to justify the lodgment of the FIR with reference to Drugs Act, 1976 as Drugs Regulatory Authority of Pakistan Act, 2012---Definition of 'drug' provided under the Drugs Regulatory Authority of Pakistan Act, 2012 was not different but included word Chinese with ayurvedic, Unani, homeopathic, biochemic system of treatment---Definition of "drugs" with reference to Drugs Regulatory Authority of Pakistan Act, 2012 would also be of no help for the department to include the "food supplement" into category of "drugs" unless the same were shown to be meant for treatment which was not the case with products of petitioner---Petitioner had claimed that in response to a letter, sent by the petitioner, the Ministry of Health had communicated that Drugs Act, 1976 was not applicable to such products---Prosecution had not denied the claim of the petitioner that companies, including petitioners, made applications for registration under the Drugs Regulatory Authority of Pakistan Act, 2012, but the authority concerned, being unable to cope with volumes of applications, issued notification dated 12.10.2015, exempting all such products from the provision of S. 7 of the Act, till 31.12.2015---Record showed that present FIR was lodged on 12.9.2015 though prior to said notification/letter but when the Authority itself exempted such products from registration then the allegation of dealing with unregistered product would not be an offence nor such allegation with reference to Drugs Regulatory Authority of Pakistan Act, 2012 could result into conviction---Facts and circumstances of the case suggested that prosecution initiated against the petitioner, was nothing but an abuse fo process of law and would never end into conviction and it would serve no purpose to let the prosecution continue---First Information Report along with all the subsequent proceedings/ consequences were quashed under Art. 199 of the Constitution accordingly. [Paras. 10, 11, 12 & 16 of the judgment]
  • Wasim Sajjad and Omar Sajjad for Petitioners.
  • Saeed A. Memon, Assistant Attorney-General, Sibtain Mehmood and Jan Muhammad, Assistant Advocate-General for the Federation.
  • 3. Learned counsel for petitioner contended that petitioner company imports food and health supplements based on herbs and natural products, and sells them in Pakistan, in 2008 in response to a letter sent by the company, Ministry of Health communicated that the Drugs Act was not applicable as it does not cover food and diet supplements provided such products are meant for nutritional purpose only and no therapeutic claims for diagnosis treatment, cure or prevention etc. of any disease is made for them; for the products imported by the company no claim is made that they are meant for treatment, mitigation, prevention or diagnosis of diseases, it was explained that the products are based on traditional Chinese medicine and not covered under the definition of drugs as provided in section 3(i) of the Act; FIR was registered against several executives of the company including its chairman who lives in China and does not deal with day today affairs of company with the allegation that products were suspected spurious, counterfeit, substandard and unregistered sold under garb of food supplement/ healthcare products which allegation is patently false. It is argued that Provincial Drug Inspector has no authority to straight away lodge FIR without first seeking orders of the Provincial Quality Control Board (PQCB) for the action proposed to be taken, as per procedure provided, on receiving a report about any contravention of the Act from Provincial Inspector and on scrutiny, PQCB issues instructions to the Inspector for action to be taken, no such instructions in present case were obtained; the notification dated 30.12.205 relied upon by Inspector to claim that he has authority to lodge FIR without instruction from PQCB is ultra-vires of section 11(5)(b) of the Act, such notification is also not placed on record by Provincial Inspector. It is pointed out that under section 11(5)(e) it is the duty of PQCB to ascertain names of directors and employees of the company responsible for commission of an offence, the Provincial Inspector at his own decided to prosecute the Directors, Chief Executive and other employees of company without any authority; that per section 30(2) of the Act all offences are non-cognizable except the one under section 27(i) therefore FIR in respect of alleged offence under section 23 of the Act is illegal, so far offence under section 27(i) is concerned, section 30(i)(a) provides that only Federal Inspector can prosecute a person. It is contended that spurious drug has been defined in section 3(zb) of the Act hence no allegation of prosecution is covered against the company under that definition; that reply of Inspector claims that products of petitioner company are covered under Drug Regulatory Authority of Pakistan Act, 2012 (DRAP Act 2012), no allegation regarding violation of DRAP Act have been made in the FIR; that DRAP Act, 2012 was promulgated on 13.11.2012 under which alternative medicine (homeopathic, Chinese, etc) were for the first time made registerable hence a large number of companies made applications for registration, the authority concerned being unable to cope with volumes of application, issued notification dated 12.10.2015 exempting all such products from provision of section 7 of that Act until 31.12.2015 hence FIR was lodged on 12.09.2015 during the time when no registration was taking place, that company had applied for registration to DRAP Act 2012 and some of its products have already been registered while others are in registration process, company is not selling any product that is not registered. Learned counsel has argued that DRAP Act, 2012 is not included in the schedule of FIA Act hence FIA has no authority to launch prosecution in respect of DRAP law, further FIR against the company mentions violation of Drugs Act, 1976 and no violation of DRAP law has been alleged; that under section 32 of DRAP law, Drugs Act, 1976 continues in force along with safeguards provided in section 11 which will govern the procedure; that per schedule IV of DRAP Act, 2012 it is the Federal Inspector who has authority in respect of import or export of therapeutic goods, Provincial Inspector has no authority.
  • "2. Learned Additional Advocate General argued that the Principal Drug Inspector had the authority to raid and to get the FIR registered against the respondents; the High Court has illegally declared the letter (mentioned in paragraph 18 of the impugned judgment) of the Provincial Quality Control Board authorizing the Drug Inspector in general terms to register FIR in his respective jurisdiction as ultra vires.
  • Here, we would add that definition of 'drug' provided under the DRAP Act is not different but includes word 'chines' with 'ayurvedic, unani, homeopathic' biochemic system of treatment'. Thus, reference to definition of 'drugs' with reference to DRAP Act would also not help for the department to include the foods supplement into category of 'drugs' unless the same are shown to be meant for treatment which is not the case with products of petitioner. Now, it can safely be concluded that above definition prima facie does not appear to have included the food or diet supplements, provided for nutritional purpose, as is being claimed by the petitioner.

Headnotes / Summary

Ss. 23, 27, 30 & 33

Drugs Regulatory Authority of Pakistan Act (XXI of 2012), Ss. 3(2b), 7, 29, 30, 32 & Sched. IV

Import, export, manufacting and sale of spurious, counterfeit, misbranded, substandard, unwarranted, unregistered, smuggled drugs

"Drug"

Definition

Scope

Quashing of FIR

Scope

Petitioner, a private limited company was engaged in business in Pakistan for the last thirteen years and imported products including perfumes, cosmetics, healthcare devices, food supplements

Such products were based on five thousand years of traditional Chinese healthcare culture and traditional methods based on plants and herbs, which being food supplements were neither drugs nor medicines, not covered by definition of "drugs" under the Drugs Act, 1976

Provincial Inspector of Drugs made a report to the FIA that petitioner company was engaged in selling, supplying, distribution of suspected spurious, counterfeit, sub-standard, unwarranted, unregistered drug products under the garb of food supplements, healthcare products which was a cognizable offence under the Act and requested FIA for joint action for inspection/raid and investigation, which was without jurisdiction

Joint Team of FIA and Provincial Inspectorate of Drugs, while acting promptly, conducted a raid at the premises of the petitioner-company and warehouse, seized various products, arrested employee and distributor of company and registered the FIR

Validity

Record showed that department had attempted to justify the lodgment of the FIR with reference to Drugs Act, 1976 as Drugs Regulatory Authority of Pakistan Act, 2012

Definition of 'drug' provided under the Drugs Regulatory Authority of Pakistan Act, 2012 was not different but included word Chinese with ayurvedic, Unani, homeopathic, biochemic system of treatment

Definition of "drugs" with reference to Drugs Regulatory Authority of Pakistan Act, 2012 would also be of no help for the department to include the "food supplement" into category of "drugs" unless the same were shown to be meant for treatment which was not the case with products of petitioner

Petitioner had claimed that in response to a letter, sent by the petitioner, the Ministry of Health had communicated that Drugs Act, 1976 was not applicable to such products

Prosecution had not denied the claim of the petitioner that companies, including petitioners, made applications for registration under the Drugs Regulatory Authority of Pakistan Act, 2012, but the authority concerned, being unable to cope with volumes of applications, issued notification dated 12.10.2015, exempting all such products from the provision of S. 7 of the Act, till 31.12.2015

Record showed that present FIR was lodged on 12.9.2015 though prior to said notification/letter but when the Authority itself exempted such products from registration then the allegation of dealing with unregistered product would not be an offence nor such allegation with reference to Drugs Regulatory Authority of Pakistan Act, 2012 could result into conviction

Facts and circumstances of the case suggested that prosecution initiated against the petitioner, was nothing but an abuse fo process of law and would never end into conviction and it would serve no purpose to let the prosecution continue

First Information Report along with all the subsequent proceedings/ consequences were quashed under Art. 199 of the Constitution accordingly. [Paras. 10, 11, 12 & 16 of the judgment]

Provisions of special law override the provisions of general law to the extent of a conflict or inconsistency between the two. [Para. 10 of the judgment]

If a particular procedure had been provided for doing a particular act then the same had to be done in that manner. [Para. 11 of the judgment]

None including an Authority was permitted to use redundant or surplus words/phrases if the language of provision was otherwise plain and unambiguous. [Para. 13 of the judgment]

Judgment & Decree

SALAHUDDIN PANHWAR, J.

Petitioners seek quashment of FIR No.44/2015 registered under sections 23 and 27 read with sections 30 and 33 of Drugs Act 1976 at PS FIA Anti-Corruption Circle, Karachi, being without lawful authority, mala fide and of no legal effect.

2. Briefly stated, relevant facts are that petitioner No.1 is a private limited company, incorporated under the Companies Ordinance, 1984, having its head office at Islamabad and Branch Office at Karachi; petitioner No.2 is its Branch Administrator at Karachi; that company is of Tiangin-Tianshi which is a multi-national, having its headquarters in China, operating various companies in 110 countries of the world with products of international reputation recognized by organizations like ISO, HACCP, GMP, etc.; petitioner company is engaged in business in Pakistan for last thirteen years and imports products including perfumes, cosmetics, healthcare devices, food supplements, etc., such products are based on five thousand years of traditional Chinese healthcare culture and traditional methods based on plants and herbs, food supplements imported which however are neither drugs nor medicines, not covered by definition of Drugs under the Drugs Act, 1976; products based on plants and herbs are excluded from definition of drugs under section 3(g)(i) of the Drugs Act, 1976 (hereinafter referred to as 'the Act'). It was stated that on 11.09.2015 respondent No.2 (Provincial Inspector of Drugs) made a false report to the FIA that petitioner company was engaged in selling/supplying/distribution of suspected spurious/counterfeit, sub-standard, unwarranted/unregistered drug products under the garb of food supplements/healthcare products which is cognizable offence under the Act and requested to FIA for joint action for inspection/raid and investigation, such request was without jurisdiction; however a joint raid team of FIA-Provincial Inspectorate of Drugs, while acting promptly, conducted a raid at premises of company at Karachi while accompanied by representatives of media and seized following imported products:- Glucosamin 500 mg Super calcium capsule with Lecithin Tiens Natto Ginkgo Capsules Tiens Super Calcium Powder with Metabolic factors Tienshi Nutrient Super Calcium Powder Tiens Multi-Vita B Tablets Tiens Super Calcium Powder for children Galaxs Membantu Memelihara Stamina Pria Breast Care apparatus. That another raid by same team was carried out at company's godown/ warehouse at Karachi and seized some of the products imported, followed by a third raid at workplace of Distributor of the company seizing various products, an employee and distributor of the company were arrested and subject FIR was registered.

3. Learned counsel for petitioner contended that petitioner company imports food and health supplements based on herbs and natural products, and sells them in Pakistan, in 2008 in response to a letter sent by the company, Ministry of Health communicated that the Drugs Act was not applicable as it does not cover food and diet supplements provided such products are meant for nutritional purpose only and no therapeutic claims for diagnosis treatment, cure or prevention etc. of any disease is made for them; for the products imported by the company no claim is made that they are meant for treatment, mitigation, prevention or diagnosis of diseases, it was explained that the products are based on traditional Chinese medicine and not covered under the definition of drugs as provided in section 3(i) of the Act; FIR was registered against several executives of the company including its chairman who lives in China and does not deal with day today affairs of company with the allegation that products were suspected spurious, counterfeit, substandard and unregistered sold under garb of food supplement/ healthcare products which allegation is patently false. It is argued that Provincial Drug Inspector has no authority to straight away lodge FIR without first seeking orders of the Provincial Quality Control Board (PQCB) for the action proposed to be taken, as per procedure provided, on receiving a report about any contravention of the Act from Provincial Inspector and on scrutiny, PQCB issues instructions to the Inspector for action to be taken, no such instructions in present case were obtained; the notification dated 30.12.205 relied upon by Inspector to claim that he has authority to lodge FIR without instruction from PQCB is ultra-vires of section 11(5)(b) of the Act, such notification is also not placed on record by Provincial Inspector. It is pointed out that under section 11(5)(e) it is the duty of PQCB to ascertain names of directors and employees of the company responsible for commission of an offence, the Provincial Inspector at his own decided to prosecute the Directors, Chief Executive and other employees of company without any authority; that per section 30(2) of the Act all offences are non-cognizable except the one under section 27(i) therefore FIR in respect of alleged offence under section 23 of the Act is illegal, so far offence under section 27(i) is concerned, section 30(i)(a) provides that only Federal Inspector can prosecute a person. It is contended that spurious drug has been defined in section 3(zb) of the Act hence no allegation of prosecution is covered against the company under that definition; that reply of Inspector claims that products of petitioner company are covered under Drug Regulatory Authority of Pakistan Act, 2012 (DRAP Act 2012), no allegation regarding violation of DRAP Act have been made in the FIR; that DRAP Act, 2012 was promulgated on 13.11.2012 under which alternative medicine (homeopathic, Chinese, etc) were for the first time made registerable hence a large number of companies made applications for registration, the authority concerned being unable to cope with volumes of application, issued notification dated 12.10.2015 exempting all such products from provision of section 7 of that Act until 31.12.2015 hence FIR was lodged on 12.09.2015 during the time when no registration was taking place, that company had applied for registration to DRAP Act 2012 and some of its products have already been registered while others are in registration process, company is not selling any product that is not registered. Learned counsel has argued that DRAP Act, 2012 is not included in the schedule of FIA Act hence FIA has no authority to launch prosecution in respect of DRAP law, further FIR against the company mentions violation of Drugs Act, 1976 and no violation of DRAP law has been alleged; that under section 32 of DRAP law, Drugs Act, 1976 continues in force along with safeguards provided in section 11 which will govern the procedure; that per schedule IV of DRAP Act, 2012 it is the Federal Inspector who has authority in respect of import or export of therapeutic goods, Provincial Inspector has no authority.

4. Learned counsel has further contended that reports from government analyst submitted in Provincial Inspector categorically state that none of the samples was found spurious, adulterated, substandard or misbranded that the case law on the subject is to the effect that provisions of section 11 of the Drugs Act, 1976 are mandatory and any FIR lodged in violation thereof is liable to be set aside. Learned counsel has relied upon 1998 PCr.LJ 181 (Agha Nadim v. SHO, PS Lahori Gate), 2005 MLD 1366 (Agha Nadim v. Province of Punjab), PLD 1985 Lahore 503 (Searle Pakistan Ltd v. The State), 2000 PCr.LJ 1644 (Sheikh Anwarul-Haq v. DIGP Lahore Range), 2006 MLD 668 (Dr. Muhammad Anwar Tanvir v. SHO, PS City Pak Patan Sharif), 1990 MLD 1524 (Abdullah Shamim v. The State), PLD 2003 Lahore 115 (Messrs Nawabsons Lab. v. Government of Punjab, Health Department), 1996 PCr.LJ 1183 (Hafiz Khalil v. The State), 1994 PCr.LJ 1065 (Shujaullah v. The State), 2000 PCr.LJ 1644 (Sheikh Anwarul-Haq v. DIGP Lahore Range) and 1996 SCMR 767 (The State v. Iqbal Ahmed Khan).

5. Learned Assistant Attorney General has argued that FIR was lodged at the complaint of Drug Inspector under its inherent jurisdiction under sections 23 and 27 read with sections 30 and 33 of the Drugs Act, 1976, that Drugs Act, 1976 does fall under the schedule attached with FIA Act as its cognizable offence; that FIA has jurisdiction to take cognizance of any offence that falls under its schedule on a complaint made to it by any person even can take such action and investigate a matter at its source report; while relying upon 2005 YLR 1515 and PLD 1976 Lahore 813, he contended that section 4(1)(f) of Cr.P.C. empowers FIA to take steps under section 154, Cr.P.C. on receipt of information either made orally or in writing relating to commission of cognizable offences followed by investigations; while referring to PLD 2009 SC 102 he contended that police have statutory duty and right under section 154, Cr.P.C. to investigate the offence cognizable whenever a report is made to it disclosing commission of offence and in such cases FIR is not liable to be quashed; that the prayer of quashment of FIR in constitutional jurisdiction is not maintainable as alternative remedy is available that section 11(5)(b) of Drugs Act, 1976 provides Provincial Quality Control Board may specify the class of cases in which a Provincial Drug Inspector may make a complaint to Drug Court or take other action without specific instructions of the Board; that in that section Drug Inspector was authorized vide Notification dated 30.12.2005 by Provincial Quality Board Government of Sindh to lodge FIR in cases falling under section 27(1) of the Drugs Act and submit complaint directly before Drug Court with consultation of Deputy District Attorney Sindh and under intimation to Provincial Quality Control Board in respect of unregistered drugs. It was pointed out that per section 16 of Drugs Act, Drug Inspector is bound to send samples for analysis to government analyst, Drugs Testing Lab/National Institute of Health. It was argued that definition of drug is modified in DRAP Act, 2012 where Unani Ayurvedic, Homeopathic, Chinese or bio-chemical system of treatment are also included in the definition, sections 3(i) and 3(v) are relevant for the purpose of present case. The petitioner claims its medicine under herbal and Chinese system of treatment hence was liable to get all their products registered with the authority but failed to do so until FIR was lodged, petitioners filed similar type of case before Peshawar High Court, which fact shows that they were in knowledge of all prevailing laws. Learned counsel explained that each system is allowed to use those ingredients which are mentioned in its system's pharmacopeias, admittedly ingredients of petitioner's medicines do not fall within the pharmacopeias of Unani (herbal)/Chinese systems, ingredients found in samples are part of allopathic pharmacopoeia of Pakistan as well as of US and British pharmacopeias hence illegal act of petitioner is evidence on its face. Learned counsel urged that remedy for quashment of FIR is also available to petitioner under section 249-A before trial Court, petitioner had obtained bail from trial court can approach the same for their grievance the apex Court had declined to interfere in case to quash FIR where alternate remedy is available as held in PLD 2013 SC 401; that case before Peshawar High Court is distinct to present case as in that case Drug Inspector had taken action under section 11 of Drugs Act and collected samples at his own and sent for laboratory test, show cause notices were also given to petitioner and after getting results he instead of submitting report to the Board for permission, directly approached the FIA for registration of FIR besides permission from board was obtained at belated stage, due to such illegality petitioner had approached High Court; such FIR was quashed with direction to Drug Inspector to adopt legal procedure; however, in instant case Drug Inspector had acted under the notification referred above and made complaint to FIA prior to taking any steps, FIA acted as per its mandate, registered FIR, proper challan was prepared by Drug inspector and after completing all formalities filed before the Drug Court that refused to be admitted due to stay order in present lis hence present petition is liable to be dismissed.

6. We have heard the respective sides as well have gone through the available material carefully.

7. At the very outset, we would take up the objection, raised by the Learned Assistant Attorney General with regard to competence of this Court for entertaining a request for quashment of an FIR in Constitutional Jurisdiction. We are conscious that normally this Court avoids entertaining a request for quashment particularly where cognizance is taken by the Court of law but there is an exception to such general principle particularly where the circumstances prima facie make it clear that continuity of such proceedings amounts in abuse to process of law. Further, the learned Assistant Attorney General also did not dispute/deny the fact that petitioner did got such like FIR quashed from Peshawar High Court which even was maintained by Honourable apex Court. Thus, we do not find any substance in such objection.

8. Reverting to the merits of the case, what we found that the Learned Assistant Attorney General have not denied the legality of the mandatory requirement, as provided by the Drugs Act, 1976 for prosecution as well dismissal of the petition by honourable apex Court whereby challenge to quashment, ordered by Peshawar High Court, was made but have attempted to seek an exception by raising plea(s), which are: i) vide Notification dated 30.12.2005, issued by Provincial Quality Board Government of Sindh, the complaint(s) of cases, falling within meaning of section 27(1) of Drugs Act, can well be prosecuted; ii) Drugs Act 1976 does fall under the schedule attached with FIA Act as its cognizable offence; iii) the definition of drug is modified in DRAP Act, 2012 where Unani, Ayurvedic, Homeopathic, Chinese or bio-chemical system of treatment are also included in the definition;

9. Since, the learned AAG while arguing did refer to decision, made by Peshawar High Court and that of honourable apex Court hence the first stand was never available as legality of such notification/letter was specifically dealt with in such decision. To make things easy, it would be proper to make a direct reference to operative part of judgment dated 04.11.2009, passed by Peshawar High Court in A.W.P. No.786/2008 which are:- "

18. Before parting with this judgment, we are constrained to hold that it is settled principle of law with regard to construction of statute laws that unless and until the legislature confer powers upon the authority having delegated powers of rules making to further delegate such powers then the authority under no circumstances can further delegate such powers, therefore, the letter of the Provincial Quality Control Board authorizing the Drugs Inspectors in general terms to register FIRs in their respective jurisdiction, is ultra vires of the statutory law, which clearly stipulate that instructions/prior approval of the Board for registration of cases in cognizable offences or for filing complaint before the Drug Courts is legally mandatory, thus, the impugned notification/letter of Provincial Quality Control Board, to the above extent is declared to be of no legal effect and without lawful authority." The said order was challenged by the department vide Civil Petition No.9-P/2010 before the apex Court but met same fate whereby the order to above extent was categorically stamped. The operative part reads as:- "

2. Learned Additional Advocate General argued that the Principal Drug Inspector had the authority to raid and to get the FIR registered against the respondents; the High Court has illegally declared the letter (mentioned in paragraph 18 of the impugned judgment) of the Provincial Quality Control Board authorizing the Drug Inspector in general terms to register FIR in his respective jurisdiction as ultra vires.

3. Heard. As regards the acts of omission and commission of the petitioner-department, which have indicated and mentioned in the impugned judgment, are concerned, those are quite obvious and manifestly render the actions of the petitioner-department and the lodging of FIR illegal. However, as has been observed by the High Court through the impugned judgment the department is not debarred to take fresh action against the respondents, after following the steps which are required by the law, thus, the department has an authority to resurrect the matter.

4. In the circumstances, we do not find any legal or factual infirmity in the impugned judgment calling for interference in the instant jurisdiction. The petition being devoid of merits stands dismissed. Leave to appeal declined."

10. Now, would take up the second and third pleas jointly, whereby the department has attempted to justify the lodgment of the FIR with reference to Drugs Act, 1976 as well with reference to DRAP Act. There can be no denial to the legally established principle of law that provisions of special law always override the provisions of general law to the extent of a conflict or inconsistency between the two. Reference may be made to the case of State Life Insurance Corp. v. Sardar Begum (2017 SCMR 999) wherein at relevant page No.1004, it is held as: "Hence where a special law determines a place of suing, which in the present case in terms of section 2(6) could be either the principal Civil Court of original jurisdiction in a district or the special Civil Jurisdiction of the Sindh High Court and Islamabad High Court, the same would prevail over the provision of section 15 of the Code of Civil Procedure. It is now trite law that the provisions of special law always override the provisions of the general law to the extent of any conflict or inconsistency between the two." Therefore, if the department attempts to stick with the Drugs Act then it (department) shall have no exception but to follow the mandatory procedure, provided by the Act itself because it is also equally settled principle of law that if a particular procedure has been provided for doing a particular act then the same has to be done in that manner. Reference may well be made to the case of Shahida Bibi and others v. Habib Bank Ltd. (PLD 2016 SC 995) wherein at relevant page 1011, it is held as: "... It is settled that where law requires an act to be done in a particular manner it has to be done in that manner alone and such dictate of law cannot be termed a mere technicality."

11. At this point, it would be fair enough to first have a direct look at the relevant provision of the Drugs Act, 1976 which deals with cognizance of offence(s) which is: "

30. Cognizance of offences.

(1) Subject to the provisions of section 19, no prosecution shall be instituted under this Chapter except - by a Federal Inspector, where the prosecution is in respect of contravention of clause (h) of subsection (1) of section 23 or section 24 or any of the provisions of this Act or the rules relating to the import or export of drugs or the manufacture for sale, or sale of a drug; which is not for the time being registered or for the manufacture for sale of which a licence is not for the time being in force; or A bare reading of the above makes it quite evident that prosecution under this Act could only be in respect of the 'drug', which too as defined by the Act itself i.e section 3(g) which reads as: 'drug' includes:- any substance or mixture of substances that is manufactured, sold, stored, offered for sale or represented for internal or external use in the treatment, mitigation, prevention or diagnosis of diseases, an abnormal physical state, or the symptoms thereof in human beings or animals or the restoration, correction, or modification of organic functions in human beings or animals not being a substance exclusively used or prepared for use in accordance with the ayurvedic, unani, homeopathic or biochemic system of , treatment except those substances and in accordance with such conditions as may be prescribed. Here, we would add that definition of 'drug' provided under the DRAP Act is not different but includes word 'chines' with 'ayurvedic, unani, homeopathic' biochemic system of treatment'. Thus, reference to definition of 'drugs' with reference to DRAP Act would also not help for the department to include the foods supplement into category of 'drugs' unless the same are shown to be meant for treatment which is not the case with products of petitioner. Now, it can safely be concluded that above definition prima facie does not appear to have included the food or diet supplements, provided for nutritional purpose, as is being claimed by the petitioner.

12. Further, there is no denial to the claim of the petitioner that in response to a letter, sent by the company, the Ministry of Health communicated that 'Drugs Act' was not applicable to such products rather the department took a somersault while taking plea that definition of 'drug' stood changed by the DRAP Act, 2012. This prima facie seems to be nothing but an attempt to 'blow hot and cold in a single breath' because the DRAP Act itself does not include such products into 'drugs' but by section 2(xv) of the Act says as: "health and OTC Products (non-drugs)" include probiotics and disinfectant, nutritional products, food supplements baby milk and foods medicated cosmetics, medicated soaps and medicated shampoos;"

13. The referral to above definition should leave it no more confusing that the 'health and OTC products' do not fall within meaning of the 'drugs' therefore, a prosecution for any violation with regard to registration of such product could only be initiated under the DRAP Act and not under the Drugs Act, 1976 because the later deals with defined 'drugs' only which too by following the procedure, provided by sections 29 and 30 of the DRAP Act. Further, we would add that per settled law none, including an authority, is permissible to use redundant or surplus words/phrases if the language of provision is otherwise plain and unambiguous. Reference may be made to the case of Zahid Javed v. Tahir Riaz Choudhry (PLD 2016 SC 637) wherein observed as: "

5. It is a cardinal principle of construction of statute that when language of the statue is plain and unambiguous, then the Court must give effect to each-words used in the statute and it would not be open to the Courts to adopt a hypothetical construction on the ground that such construction is more consistent with the alleged object and policy of the Act. It is also a settled proposition of law that the provisions of the statute have to be read as a whole and in its context. When language of the provision is plain and unambiguous the question of supplying casus omissus does not arise. The Court can interpret a law but cannot legislate. It is a familiar rule of interpretation that the word used by legislature must be construed according to its plain natural meaning and that legislature never use redundant or surplus words/phrases. What the 'Act' itself does not include into definition of 'drugs' the complainant or even the Court would not be competent to include the same into such definition, particularly in view of another trite law that the provisions of law which constitute criminal offences shall be strictly construed and applied and one cannot take an exception thereto even by making reference to two Act(s), meant to be in conformity to each other, particularly when things have been defined/categorized differently. Reference may be made to the case of Rafiq Haji Usman v. Chairman, NAB and another (2015 SCMR 1575) wherein it is held at Rel. Page-1583 as: ".... It is trite law that the provisions of law which constitute criminal offences shall be strictly construed and applied, thus prima facie we have not been persuaded by the plea made by the learned Deputy Prosecutor General that in such a case section 9(x) ibid shall be attracted."

14. Be as it may, the department claims to have lodged the FIR with reference to a letter/notification dated 30.12.2005 of PQB which notification/letter would have no relevance in respect of the offences under DRAP Act, 2012 as shall stand evident from relevant provision of Schedule-IV thereof which reads as: "SCHEDULE-IV (See Section 29) COGNIZANCE OF OFFENCES 1) Subject to the provisions of Schedule-V no prosecution shall be instituted under this Act except-- a) by a Federal Inspector, b) by a Provincial Inspector:- Provided that, where the public interest so requires, the Federal Inspector may, with the prior permission of the Registration Board or Licensing Board as the case may be, institute a prosecution for a contravention of any other provision of this Act and the Drugs Act, 1976 (XXXI of 1976). It has never been the claim of the department that there has ever been obtained any such prior permission from the Registration Board or Licensing Board, so constituted under the DRAP Act. A departure from mandatory provision of section 11 of the Drugs Act, 2012 or that of sections 29/30 of the DRAP Act, 2012 are prima facie illegalities which will never validate the manner of lodgment of FIR and subsequent effects rather such shall remain an over-stepping to the limitations, prescribed by the law itself hence will continue to be an illegality not available to be cured by prosecution during trial. Reliance is placed on the case of The State through AG v. Iqbal Ahmed Khan (1996 SCMR 767) wherein it is held as: "4. ..... This requirement of law is meant to be complied with by the prosecution and if no objection has been raised by the defence at the trial, it would not validate the proceedings which otherwise are vitiated for non-compliance of section

30. One of the main objects of all these provisions referred above is that on the one hand, there should be strict check on manufacture and sale of spurious drugs and on the other hand limitations have been placed on the powers of the Drug Inspector so that under the cloak of his authority, he may not create embarrassing situations for the manufacturer and the dealers by transgressing his powers beyond the territorial limits assigned to him. Therefore, a balance has to be maintained between the rights of the citizens and the powers of the authorities. The provisions of the Act have to be seen in this background and it was with this view that limitation on instituting prosecution has been prescribed by section

30. A prosecution can be instituted by a Federal Inspector or a Provincial Inspector. Mr. Halipota, the complainant did not hold any of the positions and was therefore, not competent to institute the case/prosecution before the Drug Court. The entire proceedings was, therefore, vitiated. The view taken by the High Court is correct and in consonance with the provisions of law." In another case, reported as Dr. Muhammad Anwar Tanvir and others v. SHO PS City Pakpattan Sharif and others (2006 MLD 668) it was held as:- "

3. After hearing, the learned counsel for the parties and going through the record of this case with their assistance it has been observed by me that the Drugs Act, 1976 as well as the Rules framed thereunder constitute a special law and they have to be given effect to as such. It is not disputed that the legal requirements and formalities mentioned in sections 11(5)(b), 19(6) and 22(3) of the Drugs Act, 1976 as well as of rule 4 of the Punjab Drugs Rules, 1988 had not been complied with in this case before registration of the impugned FIR. It has already been held in the cases of Shuja Ullah v. The State and others (1994 PCr.LJ 1065)..... that in the absence of fulfillment of the abovementioned legal requirements and formalities a criminal case cannot be registered for an offence under the Drugs Act, 1976. In the above mentioned precedent cases the FIRs registered under the Drugs Act, 1976 were quashed....." In another case, reported as Agha Nadim and another v. SHO PS Lohari Gate and others (1998 PCr.LJ 181), it is held as: 13. .... It is condition precedent under relevant provisions of the Drugs Act, 1976 and rule 4 of Drug Rules that a criminal case under section 23/27 of the Drugs Act cannot be registered without prior permission of the Quality Control Board set up under section 11 of the Act." "14. ... In absence of permission from the competent Authority the proceedings suffer from coram non judice as initiated against the mandatory provisions of law, therefore, based on mala fide and without lawful authority as held in PLD 1971 SC

124. The subsequent proceedings, based on the FIR. illegally lodged, are also bound to fall on the ground automatically, as is held in PLD 1982 Lah. 1."

15. The arguments, so raised by the learned AAG with reference to Code of Criminal Procedure are of no help as the same deals with general law and same cannot be referred/pressed for special laws particularly where mechanism for lodgment of FIR or initiation of complaint has been provided by such special law itself.

16. There is another aspect which cuts at the root of the prosecution. It is a matter of record that prosecution has not denied the claim of the petitioner that companies, including petitioners, made applications for registration under the DRAP Act but the authority concerned, being unable to cope with volumes of application, issued notification dated 12.10.2015, exempting all such products from provision of section 7 of that Act until 31.12.2015. It is also a matter of record that instant FIR was lodged on 12.09.2015 though prior to said notification/letter but when the authority itself exempted such products from registration then an allegation of dealing with unregistered product would not be an offence nor such allegation with reference to DRAP Act can result into a conviction. On this count too the prosecution shall fail. Be as it may, it is also not a claim of the department that at any time such products were included into 'drugs' or that sale of such products were prohibited/ banned till registration thereof rather an exemption granted by the authority itself was/is significant to known principle of law that if something is not prohibited by a special law then it would be presumed to be permitted. 16.(sic.) In consequence of what has been discussed above, we are of the clear view that prosecution, initiated against the petitioner, is nothing but an abuse to process of law and would never end into conviction therefore, it would serve no purpose to let such prosecution continue. Accordingly, the FIR along with all its subsequent consequences stand quashed.

17. While parting, we feel it quite necessary that there can be no denial to the fact that every food supplement (non-drug) is presented for certain effect onto the body but since it does not qualify the term 'drugs' in stricto sensu hence this may well be a reason of escape for application of the relevant laws, meant for the 'drugs' thereby giving a license to the company to sell and present such food supplement under any of the known and appealing name like the avurvedic, unani, homeopathic, Chines or bio-chemic system. One may well be interested in having good nutrition/food supplement to overcome the deficiency what the product claims but can't be sure about ingredients thereof unless the same is properly registered and is sold under a license. We can't let the desire of the people to prevail when there is even a slightest possibility that such pill (unknown ingredients) would bring consequences other than the claimed one. This has been the reason of introduction of the DRAP Act which for the first time bring 'non-drug' products to be regulated properly. However, what is alarming was the pleaded fact that the authority, being unable to cope-up with requests for registration of food supplements etc, had to exempt registration thereof. In consequence whereof, the license was granted to continue doing such business under a claim of the company and under the Authority. Such amount request for registrations is another fact that the business of products under claim of food supplement/nutrition has abnormally increased and such products are swallowed which admittedly are not registered with the Authority, so established under the DRAP Act, 2012. Things cannot be allowed to continue so nor legally can the Authority exempt requirement of law (Registration of drugs and non-drugs) from registration as has been claimed. The Authority may get hands to cope-up with heap of requests but can't exempt/relax the requirements of the law. Therefore, we find in all fairness to direct the Authority, so constituted under DRAP Act, to ensure completion of process of registration or otherwise of the pending requests/applications for drugs and non-drugs within shortest possible time which however should last within six months. The Authority shall also activate all its hands to ensure that not a single drugs or non-drugs is marketed/sold without its proper registration but no action shall be taken but strictly in accordance with dictates of the law. JK/T-7/Sindh FIR quashed.